INPLASY202230111

A retrospective integrated analysis evaluate the effect and safety of Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy

Keywords: primary biliary cholangitis; randomized controlled trial; fenofibrate; odds ratio; combination therapy; monotherapy; meta-analysis.

Review Status: Ongoing